S. Mangano

530 total citations
20 papers, 331 citations indexed

About

S. Mangano is a scholar working on Hepatology, Epidemiology and Emergency Medical Services. According to data from OpenAlex, S. Mangano has authored 20 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 9 papers in Epidemiology and 4 papers in Emergency Medical Services. Recurrent topics in S. Mangano's work include Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (6 papers). S. Mangano is often cited by papers focused on Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (6 papers). S. Mangano collaborates with scholars based in Italy, United States and Sweden. S. Mangano's co-authors include F. Fabrizi, G. Lunghi, Paul Martin, Piergiorgio Messa, Filippo Aucella, Francesco Locatelli, Simeone Andrulli, Elena Rusconi, M. Villa and A. Pagano and has published in prestigious journals such as Cancer Research, Kidney International and Frontiers in Immunology.

In The Last Decade

S. Mangano

19 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Mangano Italy 10 244 240 42 28 24 20 331
V. Piazza Italy 7 180 0.7× 159 0.7× 73 1.7× 29 1.0× 9 0.4× 20 305
María Antonia Álvarez de Lara Spain 6 187 0.8× 157 0.7× 125 3.0× 72 2.6× 16 0.7× 7 334
Maria Covic Romania 7 46 0.2× 51 0.2× 126 3.0× 44 1.6× 28 1.2× 15 344
A.S. Lok United States 9 194 0.8× 188 0.8× 6 0.1× 78 2.8× 27 1.1× 19 298
Nasir Hassan Luck Pakistan 9 93 0.4× 118 0.5× 7 0.2× 94 3.4× 37 1.5× 65 266
Joseph J. Alukal United States 11 137 0.6× 165 0.7× 14 0.3× 80 2.9× 36 1.5× 31 274
Teresa L. Wright United States 8 402 1.6× 302 1.3× 7 0.2× 124 4.4× 11 0.5× 9 463
Cécile Denié France 9 239 1.0× 151 0.6× 14 0.3× 182 6.5× 27 1.1× 15 329
R. Solà Spain 6 242 1.0× 234 1.0× 17 0.4× 86 3.1× 10 0.4× 15 288
Jeremy Rajanayagam Australia 8 199 0.8× 162 0.7× 5 0.1× 154 5.5× 20 0.8× 15 391

Countries citing papers authored by S. Mangano

Since Specialization
Citations

This map shows the geographic impact of S. Mangano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Mangano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Mangano more than expected).

Fields of papers citing papers by S. Mangano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Mangano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Mangano. The network helps show where S. Mangano may publish in the future.

Co-authorship network of co-authors of S. Mangano

This figure shows the co-authorship network connecting the top 25 collaborators of S. Mangano. A scholar is included among the top collaborators of S. Mangano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Mangano. S. Mangano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cavalluzzo, Beatrice, et al.. (2025). Abstract 856: Exploiting the molecular mimicry for preventive/therapeutic cancer vaccine development. Cancer Research. 85(8_Supplement_1). 856–856.
2.
Ragone, Concetta, et al.. (2024). Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization. Frontiers in Immunology. 15. 1398002–1398002. 2 indexed citations
3.
Bellasi, Antonio, Giuseppina Melfa, Carlo Ratti, et al.. (2017). [New oral anticoagulants (NOAC) in nephrology].. PubMed. 33(4). 3 indexed citations
4.
Fabrizi, F., S. Mangano, T. Stellato, Paul Martin, & Piergiorgio Messa. (2013). Lamivudine treatment for hepatitis B in dialysis population : case reports and literature review.. PubMed. 76(4). 423–8. 2 indexed citations
5.
Liverani, Carlo Antonio, Andrea Ciavattini, Ermelinda Monti, et al.. (2012). High risk HPV DNA subtypes and E6/E7 mRNA expression in a cohort of colposcopy patients from Northern Italy with high-grade histologically verified cervical lesions.. PubMed. 4(4). 452–7. 6 indexed citations
6.
Bonforte, Giuseppe, Daniela Pogliani, Marco DʼAmico, et al.. (2010). Validation of QB stress test as a useful tool in the detection of native arteriovenous fistula stenosis: results after 22 months of follow-up. Nephrology Dialysis Transplantation. 25(6). 1943–1949. 8 indexed citations
7.
Fabrizi, F., et al.. (2008). Kinetics of hepatitis B virus load and haemodialysis: a prospective study. Journal of Viral Hepatitis. 15(12). 917–921. 11 indexed citations
8.
DʼAmico, Marco, et al.. (2008). [From the Mailing List SIN: Epidemic of infections caused by 'aquatic' bacteria in patients undergoing hemodialysis via central venous catheters].. PubMed. 22(5). 508–13. 5 indexed citations
9.
Fabrizi, F., Amedeo F. De Vecchi, Abdul Rashid Qureshi, et al.. (2007). Gamma Glutamyltranspeptidase Activity and Viral Hepatitis in Dialysis Population. The International Journal of Artificial Organs. 30(1). 6–15. 13 indexed citations
10.
Fabrizi, F., Annette Bruchfeld, S. Mangano, et al.. (2007). Interferon Therapy for HCV-Associated Glomerulonephritis: Meta-Analysis of Controlled Trials. The International Journal of Artificial Organs. 30(3). 212–219. 30 indexed citations
11.
Filippo, Salvatore Di, Simeone Andrulli, S. Mangano, et al.. (2006). Reduction in urea distribution volume over time in clinically stable dialysis patients. Kidney International. 69(4). 754–759. 1 indexed citations
12.
Fabrizi, F., Pietro Lampertico, G. Lunghi, et al.. (2005). Review article: hepatitis C virus infection and type‐2 diabetes mellitus in renal diseases and transplantation. Alimentary Pharmacology & Therapeutics. 21(6). 623–632. 22 indexed citations
13.
Fabrizi, F., Piergiorgio Messa, G. Lunghi, et al.. (2005). Occult hepatitis B virus infection in dialysis patients: a multicentre survey. Alimentary Pharmacology & Therapeutics. 21(11). 1341–1347. 76 indexed citations
14.
Fabrizi, F., S. Mangano, Patrizia Colucci, et al.. (2003). [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].. PubMed. 19(2). 149–54. 1 indexed citations
15.
Fabrizi, F., et al.. (2003). Influence of Hepatitis B Virus Virema upon Serum Aminotransferase Activity in Dialysis Population. The International Journal of Artificial Organs. 26(12). 1048–1055. 24 indexed citations
16.
Locatelli, Francesco, Simeone Andrulli, Salvatore Di Filippo, et al.. (1998). Effect of on-line conductivity plasma ultrafiltrate kinetic modeling on cardiovascular stability of hemodialysis patients. Kidney International. 53(4). 1052–1060. 39 indexed citations
17.
Mangano, S., et al.. (1998). Vascular catheter apparently well-placed. Nephrology Dialysis Transplantation. 13(3). 799–800. 1 indexed citations
18.
Fabrizi, F., G. Lunghi, Simeone Andrulli, et al.. (1997). Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Nephrology Dialysis Transplantation. 12(7). 1394–1398. 56 indexed citations
19.
Fabrizi, F., et al.. (1997). Molecular Epidemiology of Hepatitis C Virus Infection in Dialysis Patients. Nephron. 77(2). 190–196. 13 indexed citations
20.
Mangano, S., et al.. (1992). Prevalence of Antibodies against Hepatitis C Virus in a Dialysis Unit. ˜The œNephron journals/Nephron journals. 61(3). 337–338. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Piazza Breakdown of academic impact, for papers by María Antonia Álvarez de Lara Breakdown of academic impact, for papers by Maria Covic Breakdown of academic impact, for papers by A.S. Lok Breakdown of academic impact, for papers by Nasir Hassan Luck Breakdown of academic impact, for papers by Joseph J. Alukal Breakdown of academic impact, for papers by Teresa L. Wright Breakdown of academic impact, for papers by Cécile Denié Breakdown of academic impact, for papers by R. Solà Breakdown of academic impact, for papers by Jeremy Rajanayagam
Rankless by CCL
2026